“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the brains of people living with Alzheimer’s, preventing it from clumping together,” said Richard Oakley, associate director of research and innovation at the Alzheimer’s Society UK, which funded the research.

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at preventing the buildup of Tau proteins

Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can prevent the build-up of toxic proteins in the brain that lead to neurodegenerative issues causing Alzheimer’s disease.

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to the memory robbing condition getting worse.

New study is a promising ‘first’ in Alzheimer’s drug development - Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative diseases.